vs
Phathom Pharmaceuticals, Inc.（PHAT）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
Phathom Pharmaceuticals, Inc.的季度营收约是READING INTERNATIONAL INC的1.1倍（$57.6M vs $50.3M），Phathom Pharmaceuticals, Inc.同比增速更快（94.1% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-167.0M）
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
PHAT vs RDI — 直观对比
营收规模更大
PHAT
是对方的1.1倍
$50.3M
营收增速更快
PHAT
高出108.3%
-14.2%
自由现金流更多
RDI
多$171.1M
$-167.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.6M | $50.3M |
| 净利润 | — | $-2.6M |
| 毛利率 | 86.7% | — |
| 营业利润率 | — | -1.9% |
| 净利率 | — | -5.1% |
| 营收同比 | 94.1% | -14.2% |
| 净利润同比 | 71.6% | -14.5% |
| 每股收益（稀释后） | — | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PHATRDI
| Q4 25 | $57.6M | $50.3M | ||
| Q3 25 | $49.5M | $52.2M | ||
| Q2 25 | $39.5M | $60.4M | ||
| Q1 25 | $28.5M | $40.2M | ||
| Q4 24 | $29.7M | $58.6M | ||
| Q3 24 | $16.4M | $60.1M | ||
| Q2 24 | $7.3M | $46.8M | ||
| Q1 24 | — | $45.1M |
净利润PHATRDI
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-30.0M | $-4.2M | ||
| Q2 25 | $-75.8M | $-2.7M | ||
| Q1 25 | $-94.3M | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-85.6M | $-7.0M | ||
| Q2 24 | $-91.4M | $-12.8M | ||
| Q1 24 | — | $-13.2M |
毛利率PHATRDI
| Q4 25 | 86.7% | — | ||
| Q3 25 | 87.5% | — | ||
| Q2 25 | 87.2% | — | ||
| Q1 25 | 86.9% | — | ||
| Q4 24 | 87.1% | — | ||
| Q3 24 | 85.6% | — | ||
| Q2 24 | 81.2% | — | ||
| Q1 24 | — | — |
营业利润率PHATRDI
| Q4 25 | — | -1.9% | ||
| Q3 25 | -30.8% | -0.6% | ||
| Q2 25 | -151.7% | 4.8% | ||
| Q1 25 | -276.5% | -17.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | -433.0% | -0.6% | ||
| Q2 24 | -1055.4% | -16.4% | ||
| Q1 24 | — | -16.7% |
净利率PHATRDI
| Q4 25 | — | -5.1% | ||
| Q3 25 | -60.5% | -8.0% | ||
| Q2 25 | -191.9% | -4.4% | ||
| Q1 25 | -330.7% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -523.3% | -11.7% | ||
| Q2 24 | -1248.6% | -27.4% | ||
| Q1 24 | — | -29.4% |
每股收益（稀释后）PHATRDI
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.41 | $-0.18 | ||
| Q2 25 | $-1.05 | $-0.12 | ||
| Q1 25 | $-1.31 | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | $-1.32 | $-0.31 | ||
| Q2 24 | $-1.56 | $-0.57 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $130.0M | $10.5M |
| 总债务越低越好 | $209.1M | $185.1M |
| 股东权益账面价值 | $-438.2M | $-18.2M |
| 总资产 | $259.1M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PHATRDI
| Q4 25 | $130.0M | $10.5M | ||
| Q3 25 | $135.2M | $8.1M | ||
| Q2 25 | $149.6M | $9.1M | ||
| Q1 25 | $212.3M | $5.9M | ||
| Q4 24 | $297.3M | $12.4M | ||
| Q3 24 | $334.7M | $10.1M | ||
| Q2 24 | $276.2M | $9.3M | ||
| Q1 24 | — | $7.5M |
总债务PHATRDI
| Q4 25 | $209.1M | $185.1M | ||
| Q3 25 | $207.1M | — | ||
| Q2 25 | $205.1M | — | ||
| Q1 25 | $203.2M | — | ||
| Q4 24 | $201.4M | $202.7M | ||
| Q3 24 | $175.7M | — | ||
| Q2 24 | $174.4M | — | ||
| Q1 24 | — | — |
股东权益PHATRDI
| Q4 25 | $-438.2M | $-18.2M | ||
| Q3 25 | $-422.5M | $-12.1M | ||
| Q2 25 | $-405.8M | $-7.7M | ||
| Q1 25 | $-338.4M | $-8.1M | ||
| Q4 24 | $-253.6M | $-4.4M | ||
| Q3 24 | $-187.1M | $1.6M | ||
| Q2 24 | $-233.8M | $6.5M | ||
| Q1 24 | — | $18.0M |
总资产PHATRDI
| Q4 25 | $259.1M | $434.9M | ||
| Q3 25 | $240.3M | $435.2M | ||
| Q2 25 | $250.2M | $438.1M | ||
| Q1 25 | $294.2M | $441.0M | ||
| Q4 24 | $378.3M | $471.0M | ||
| Q3 24 | $387.0M | $495.7M | ||
| Q2 24 | $319.4M | $494.9M | ||
| Q1 24 | — | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-166.8M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-167.0M | $4.1M |
| 自由现金流率自由现金流/营收 | -290.0% | 8.2% |
| 资本支出强度资本支出/营收 | 0.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-328.9M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流PHATRDI
| Q4 25 | $-166.8M | $4.3M | ||
| Q3 25 | $-14.1M | $295.0K | ||
| Q2 25 | $-62.7M | $1.6M | ||
| Q1 25 | $-84.9M | $-7.7M | ||
| Q4 24 | $-266.8M | $8.0M | ||
| Q3 24 | $-63.6M | $1.3M | ||
| Q2 24 | $-70.7M | $-10.4M | ||
| Q1 24 | — | $-2.8M |
自由现金流PHATRDI
| Q4 25 | $-167.0M | $4.1M | ||
| Q3 25 | $-14.1M | $-246.0K | ||
| Q2 25 | $-62.8M | $1.2M | ||
| Q1 25 | $-84.9M | $-8.0M | ||
| Q4 24 | $-266.9M | $7.0M | ||
| Q3 24 | $-63.6M | $-1.1M | ||
| Q2 24 | $-70.8M | $-10.6M | ||
| Q1 24 | — | $-4.7M |
自由现金流率PHATRDI
| Q4 25 | -290.0% | 8.2% | ||
| Q3 25 | -28.6% | -0.5% | ||
| Q2 25 | -159.0% | 1.9% | ||
| Q1 25 | -297.9% | -19.8% | ||
| Q4 24 | -899.8% | 12.0% | ||
| Q3 24 | -389.0% | -1.8% | ||
| Q2 24 | -966.2% | -22.7% | ||
| Q1 24 | — | -10.4% |
资本支出强度PHATRDI
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.1% | 1.0% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.5% | 1.7% | ||
| Q3 24 | 0.3% | 4.0% | ||
| Q2 24 | 0.6% | 0.5% | ||
| Q1 24 | — | 4.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PHAT
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
